Advanced Filters
noise

Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,190 clinical trials
D Dominique GENRE, MD

Institut Paoli Calmettes Acute Leukemia Database

Database of Institut Paoli-Calmettes patients diagnosed with Acute Leukemia

18 years of age All Phase N/A
D Dominique GENRE, MD

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

Database of Institut Paoli-Calmettes patients diagnosed with chronic lymphatic leukemia

18 - 95 years of age All Phase N/A

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

This is an observational (non-interventional), prospective, cohort study that will collects data from patients diagnosed with relapsed or refractory acute myeloid leukemia afferent to the participanting clinical sites

6 years of age All Phase N/A
L Lele Zhang, PhD

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Hematological diseases are disorders of the blood and hematopoietic organs. The current hematological cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in hematology. The objectives of this study are to …

years of age All Phase N/A
A Adrien CONTEJEAN, MD

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

This observational epidemiological study targets patients aged 60 and over with de novo or secondary acute myeloblastic leukemia suitable for intensive receive intensive induction therapy as defined by the group. The main aim of the study is to determine the epidemiological characteristics of AML patients, both clinically and biologically, and …

60 years of age All Phase N/A

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

This is a retrospective observational research study to describe the characteristics and real-world clinical outcomes of patients with chronic lymphocytic leukaemia receiving acalabrutinib in the United Kingdom (the EPIC study). Physicians treating chronic lymphocytic leukaemia patients with acalabrutinib, where the patients started treatment as part of the acalabrutinib Early Access …

18 - 130 years of age All Phase N/A
K Kam Tong LEUNG, Ph. D.

Advanced Translational Research on Childhood Leukemia

Prognosis of children with leukemia, the most common pediatric cancer, has improved markedly. Yet, relapse still occurs in 15-40% of patients with a probability of survival of <50%, which is unlikely to be boosted by intensification of standard chemotherapy due to overwhelming toxicity. The advent of effective and safe targeted …

- 18 years of age All Phase N/A
W Wen-Chien Chou, MD. PhD.

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

In recent years, the goal of stopping drug therapy, also known as treatment-free remission (TFR), is emerging as one of the management goals of chronic myeloid leukemia (CML) therapy. Because there is no available data on Asian patients with CML undergoing tyrosine kinase inhibitor discontinuation (TKI), the investigators plan to …

20 years of age All Phase N/A
M Michaela Weier

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies is integrated. Prospective population-based non-interventional and non-randomized multicenter registry.

18 years of age All Phase N/A
J Jamile Frayfer

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

Mutations in IDH genes are found in numerous cancers and more specifically in acute myeloid leukemia (AML). These mutations target specific amino acids, at positions 140 or 172 of IDH2, and 132 of IDH1. Mutant IDH proteins acquire an abnormal enzymatic activity allowing them to convert α-ketoglutarate (αKG) into D-2 …

18 years of age All Phase N/A

Simplify language using AI